This inventor holds 2 USPTO granted patents. Top assignees: Amgen Research (Munich) Gmbh, Micromet Ag. Active years: 2011-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2018
Title: Eva Vieser: Innovator in Antibody Research
Introduction
Eva Vieser, nee Krinner, is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of antibody research, particularly in the development of neutralizers for human granulocyte macrophage colony-stimulating factor (GM-CSF). With a total of 2 patents to her name, her work has implications for therapeutic applications in various medical conditions.
Latest Patents
Eva Vieser's latest patents focus on human monoclonal antibodies that specifically bind to and neutralize primate GM-CSF. These inventions are crucial for advancing treatments that target immune responses, showcasing her innovative approach to addressing complex biological challenges.
Career Highlights
Throughout her career, Eva has worked with notable companies such as Micromet AG and Amgen Research (Munich) GmbH. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Eva has collaborated with talented individuals, including Tobias Raum and Julia Hepp, nee Henckel. These partnerships have enriched her research and fostered a collaborative environment that encourages innovation.
Conclusion
Eva Vieser is a remarkable inventor whose work in antibody research continues to impact the medical field. Her dedication to innovation and collaboration highlights the importance of scientific advancement in improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile